This study confirmed that Sch B alleviates EMT in RTCs in diabetes mellitus by effectively blocking the TGF-β1 pathway, along with a consequent elevation in the α-SMA level and reduction in the E-cadherin level. Here, CDH1 is linked to diabetes mellitus.